Security key
471871202
Jasper Therapeutics, Inc. - Voting Common Stock (JSPR)
CUSIP: 471871202
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Voting Common Stock
- Shares outstanding
- 27,779,583
- Total 13F shares
- 20,155,363
- Share change
- +7,641,068
- Total reported value
- $47,814,871
- Put/Call ratio
- 61%
- Price per share
- $2.38
- Number of holders
- 60
- Value change
- +$13,375,643
- Number of buys
- 31
- Number of sells
- 37
Report period
Q3 2025
Institutions
60
Top holders
10
JSPR full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 471871202
Recent filing periods:
Top shareholders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Velan Capital Investment Management LP |
3/4/5
13D/G
13F
|
10%+ Owner · Company |
9.6%
from 13D/G
|
1,433,828
|
$18,568,073 | — | 08 Feb 2024 | |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
|
Company |
7.1%
|
2,057,612
|
$4,897,117 | $0 | 30 Sep 2025 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
684,707
|
$3,800,124 | — | 30 Jun 2025 | |
| Qiming U.S. Healthcare Fund II, L.P. |
3/4/5
13D/G
|
10%+ Owner |
3.3%
from 13D/G
|
8,519,648
|
$5,525,844 | — | 27 Jan 2023 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
1.5%
|
225,605
|
$1,252,311 | $0 | 30 Jun 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
5.4%
|
1,494,420
|
$8,294,031 | — | 30 Jun 2025 | |
| Carlyle Group Inc. |
3/4/5
13F
|
Former 10% Owner · Company |
3.8%
from 13F
|
1,066,189
|
$13,807,148 | — | 08 Feb 2024 | |
| Qiming U.S. Ventures Management, LLC |
13F
|
Company |
3.3%
|
928,964
|
$5,155,750 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.8%
|
769,750
|
$4,272,114 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
624,597
|
$3,466,514 | — | 30 Jun 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
2.1%
|
590,000
|
$3,274,500 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2%
|
545,171
|
$3,025,699 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.9%
|
534,713
|
$2,967,657 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
1.5%
|
416,275
|
$2,310,326 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.5%
|
410,444
|
$2,277,965 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
293,460
|
$1,628,703 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.9%
|
249,793
|
$1,386,352 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.58%
|
160,000
|
$888,000 | — | 30 Jun 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.57%
|
158,133
|
$877,638 | — | 30 Jun 2025 | |
| Lion Point Capital, LP |
13F
|
Company |
0.53%
|
146,500
|
$813,075 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.52%
|
145,219
|
$805,965 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.48%
|
132,905
|
$737,623 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
131,130
|
$728,040 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.23%
|
65,088
|
$361,238 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.22%
|
60,886
|
$337,917 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.18%
|
50,686
|
$281,307 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
44,754
|
$248,385 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.16%
|
44,661
|
$247,869 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
35,533
|
$197,208 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
34,908
|
$193,739 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.1%
|
27,348
|
$151,781 | — | 30 Jun 2025 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.1%
|
26,656
|
$147,941 | — | 30 Jun 2025 | |
| Mariner, LLC |
13F
|
Company |
0.09%
|
25,513
|
$141,597 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.09%
|
25,379
|
$140,853 | — | 30 Jun 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.09%
|
25,107
|
$139,344 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.07%
|
18,856
|
$104,651 | — | 30 Jun 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
18,353
|
$101,859 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
17,789
|
$99,000 | — | 30 Jun 2025 | |
| Sowell Financial Services LLC |
13F
|
Company |
0.06%
|
17,303
|
$96,032 | — | 30 Jun 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.05%
|
15,025
|
$83,000 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.05%
|
14,797
|
$82,000 | — | 30 Jun 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.05%
|
14,671
|
$81,424 | — | 30 Jun 2025 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.05%
|
13,972
|
$77,545 | — | 30 Jun 2025 | |
| Marex Group plc |
13F
|
Company |
0.05%
|
13,300
|
$73,815 | — | 30 Jun 2025 | |
| Jain Global LLC |
13F
|
Company |
0.04%
|
12,130
|
$67,322 | — | 30 Jun 2025 | |
| Sequent Planning LLC |
13F
|
Company |
0.04%
|
10,500
|
$58,275 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
10,400
|
$57,720 | — | 30 Jun 2025 | |
| Corton Capital Inc. |
13F
|
Company |
0.04%
|
10,004
|
$55,522 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,747
|
$20,796 | — | 30 Jun 2025 | |
| Crewe Advisors LLC |
13F
|
Company |
0.01%
|
3,100
|
$17,205 | — | 30 Jun 2025 |
Institutional Holders of Jasper Therapeutics, Inc. - Voting Common Stock (JSPR) as of Q3 2025
As of 30 Sep 2025,
Jasper Therapeutics, Inc. - Voting Common Stock (JSPR) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,155,363 shares.
The largest 10 holders included
Velan Capital Investment Management LP, Soleus Capital Management, L.P., ACORN CAPITAL ADVISORS, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Rock Springs Capital Management LP, Carlyle Group Inc., Woodline Partners LP, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., and Propel Bio Management, LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
63
Q3 2025 holders
60
Holder diff
-3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.